1. Turkey Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Seyitler Kimya Sanayi AS

Seyitler Kimya Sanayi AS

BBIST:SEYKM
2.44
TRY
-0.06
(-2.40%)
0.14EPS
31.52P/E
884.00MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.17
0.14
0.14
0.16
0.23
0.31
0.5
0.62
2.6
2.04
1.5
1.21
1.28
Basic EPS, GAAP
0.03
0.02
0.02
0.02
0.02
0.05
0.19
0.25
0.62
-0.53
-0.58
-0.2
0.14
Free Cash Flow per Basic Share
-0.03
-0.01
0.01
-0.01
- -
0.03
-0.21
0.14
-0.41
0.55
-0.51
0.36
0.32
Dividend per Share
0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.1
0.15
0.16
0.19
0.22
0.26
0.45
0.68
2.03
2.42
2.67
2.48
2.87
Tangible Book Value per Share
0.1
0.15
0.16
0.19
0.22
0.26
0.45
0.68
2.03
2.41
2.67
2.47
2.86
Basic Weighted Avg Shares
76
97
106
106
106
106
106
96
82
139
200
200
200
Sales/Revenue/Turnover
13
13
14
17
24
33
53
60
213
283
300
242
256
Operating Margin (%)
19.26
16.34
16.64
10.81
10.98
12.07
16.87
13.79
26.28
2.37
-9.13
-8.24
-6.37
Depreciation Expense
- -
1
- -
1
1
1
1
2
8
13
19
20
20
Net Income, GAAP
2
2
3
2
3
5
20
24
51
-74
-115
-39
28
Effective Tax Rate (%)
1.45
19.05
7.27
13.69
22.39
14.99
0.28
0.79
27.52
- -
- -
- -
2.05
Profit Margin (%)
18.88
13.07
18.29
11
10.95
14.54
38.18
40.43
23.97
-26.07
-38.44
-16.3
10.93
Working Capital
7
9
10
13
13
17
44
61
249
233
359
372
407
LT Debt
- -
- -
- -
- -
- -
- -
9
6
24
18
- -
- -
- -
Total Equity
10
15
17
20
23
28
48
72
282
335
534
495
573
Return on Invested Capital (%)
- -
13.55
14.11
8.02
11.5
14.03
19.72
9.45
16.14
- -
- -
- -
-3.53
Return on Capital (%)
- -
13.52
16.13
11
13.48
20.69
50.03
36.67
26.5
- -
- -
- -
7.24
Return on Common Equity (%)
- -
13.99
16.57
10.14
12.21
19.03
53.49
40.52
28.83
-23.92
-26.57
-7.67
5.56

Capital Structure

TRY

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
200
200
200
Market Capitalization
1,436
1,006
884

Working Capital

TRY

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
377
428
477
Cash, Cash Equivalents & STI
238
254
270
Accounts Receivable, Net
31
52
75
Inventories
89
96
108
Total Current Liabilities
41
55
70
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
55.22%
82.43%
-7.37%
Free Cash Flow
-205.54%
-247.12%
-170.57%
Net Income, GAAP
34.19%
-24.71%
-65.82%
Sales/Revenue/Turnover
45.22%
57.45%
-19.37%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
58
54
95
65
300
2025
73
48
50
77
242
2026
82
- -
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.14
0.51
-0.18
-0.09
-0.58
2025
-0.09
-0.03
0.03
- -
-0.2
2026
0.14
- -
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
Full Time Employees
64
Sector
Health technology
Industry
Medical specialties
Address
Manisa Turkey
IPO Date
Aug 3, 2015
Website
seyitler.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Seyitler Kimya Sanayi AS is a Turkey-based healthcare manufacturing company that specializes in the research, development, and production of medical adhesive tapes, therapeutic plasters, and advanced wound care consumables. Founded in 1991 and headquartered in Izmir, Turkey, with primary manufacturing operations located in Turgutlu, Manisa, the company operates within the medical devices and healthcare consumables sector. Seyitler Kimya Sanayi AS manufactures and distributes a diversified product portfolio categorized into surgical tapes and fixation products, including microporous paper tapes, silk surgical tapes, fabric tapes, transparent polyethylene tapes, and non-woven retention tapes; wound care and first-aid supplies, comprising sterile wound dressings, hypoallergenic adhesive bandages, injection plasters, IV cannula fixation dressings, eye pads, and transparent film dressings; therapeutic plasters, featuring capsicum perforated warming plasters, menthol patches, and medicated pain-relief plasters; sports and orthopedic products, including rigid athletic strapping tapes, kinesiology tapes, cohesive flexible bandages, and elastic compression bandages; and customized adhesive materials, encompassing medical-grade hotmelt, zinc oxide, and acrylic adhesive coating formulations. The company markets its products under proprietary brand names, including Doktor Plaster and Fixroll, while also providing contract manufacturing and private-label production services for domestic and global pharmaceutical companies, hospital networks, wholesale distributors, and retail pharmacy chains across Europe, the Middle East, Central Asia, and Africa. In recent strategic and operational developments, Seyitler Kimya Sanayi AS has executed modernization and capacity expansion initiatives at its Manisa production facility, installing high-speed automated slitting and sterile cleanroom packaging equipment to increase output. The company has expanded its product offerings with the introduction of sensitive-skin silicone adhesive dressings and enhanced postoperative barrier films designed for hospital and institutional healthcare settings. In addition, the company has invested in sustainability and operational efficiency by completing a rooftop solar photovoltaic power plant installation to reduce energy overhead, while simultaneously strengthening its international export distribution alliances and undertaking capital structure enhancements to support ongoing commercial growth.